Friedman Mark Louis
SEC CIK 1531023 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AXGN | Axogen, Inc. | VP Regulatory Affairs, Policy | 25.8K | — | — | 10 | 2021-07-19 | 2022-03-16 |
Most active insiders at AXGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Began Marc A | EVP, GC | — | $3.88M |
| 2 | Burke William P. Mr. | Dir | — | $2.82M |
| 3 | Weiler Kathy Johnson | Dir | — | $2.74M |
| 4 | DALE MICHAEL D | CEO | — | $2.67M |
| 5 | Wendell Amy McBride | Dir | — | $2.00M |
| 6 | JOHNSON JOHN | Dir | — | $1.87M |
| 7 | TYNDALL JOSEPH A. | Dir | — | $951.8K |
| 8 | Hartley Lindsey Marie | CFO | — | $942.2K |
| 9 | DeVinney Erick Wayne | Chief Innovation Off | — | $780.6K |
| 10 | THOMAS PAUL | Dir | — | $633.6K |
Friedman Mark Louis made no open-market trades at AXGN in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-18 | 2022-03-16 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | M - OptEx | $0.00 | +6,000 | 25.8K | +30% | $0 |
| D | 2022-03-18 | 2022-03-16 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | F - Tax | $7.97 | -1,502 | 24.3K | -6% | -$12.0K |
| 2022-02-17 | 2022-02-15 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | F - Tax | $8.42 | -357 | 19.8K | -2% | -$3,006 | |
| 2022-02-17 | 2022-02-15 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | A - Grant | $0.00 | +1,181 | 20.2K | +6% | $0 | |
| D | 2021-12-29 | 2021-12-27 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | M - OptEx | $0.00 | +1,150 | 17.7K | +7% | $0 |
| D | 2021-12-29 | 2021-12-27 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | F - Tax | $9.74 | -286 | 17.5K | -2% | -$2,786 |
| D | 2021-12-22 | 2021-12-20 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | M - OptEx | $0.00 | +375 | 16.7K | +2% | $0 |
| D | 2021-12-22 | 2021-12-20 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | F - Tax | $9.24 | -95 | 16.6K | -0.6% | -$877.80 |
| 2021-07-21 | 2021-07-20 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | F - Tax | $19.20 | -637 | 16.3K | -4% | -$12.2K | |
| 2021-07-21 | 2021-07-19 | AXGN | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affairs, Policy | A - Grant | $0.00 | +2,572 | 16.9K | +18% | $0 |
Purchase Sale Sale after option exercise All abbreviations